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This Month in the Journal
The lack of reproducibility for genetic analyses of pros-
tate cancer has been a frustrating aspect of this field.
This month in the Journal, Elaine Ostrander and Janet
Stanford have contributed a review (p. 1367) in which
they discuss the lessons that researchers have learned
from studies of prostate cancer genetics. They also pro-
vide an outline of the challenges facing this field, in-
cluding genetic heterogeneity and phenotype variability.
Although progress in this field has been slow, the recent
cloning and confirmation of theHPC2/ELAC2 locus for
prostate cancer (see the review’s citations of work by
Tavtigian et al. and Rebbeck et al.) give hope that the
tide is turning.
Also in this issue is an editorial by Jeff Lell and Doug
Wallace (p. 1376) on the peopling of Europe. They dis-
cuss recent work by Richards et al. (in the November
2000 issue [p. 1251–1276]) and by Rosser et al. (in this
issue [p. 1526]), who have used mtDNA and Y chro-
mosomes, respectively, to study genetic lineages in Eu-
rope. Through these studies, the influences that such
factors as geography, language, and migration have had
on the history of Europe have been further explored.
Although, because of the different methods used, it is
difficult to make direct comparisons between the two
papers, both works provide some support for the spread
of agriculture via migrations of Near Eastern farmers
into Europe during the Neolithic.
FOXC2 Mutations in Lymphedema-Distichiasis, by
Fang et al. (p. 1382)
Through use of a patient with a t(Y;16)(q12:q24.3) that
is associated with neonatal lymphedema, Fang et al. have
been able to identify the gene for lymphedema-distichi-
asis (LD) as the FOXC2 gene. LD is an autosomal dom-
inant disorder in which affected individuals have double
rows of eyelashes (distichiasis) and lymphedema in the
limbs. Several other tissues may be affected, leading to
cleft palate, extradural cysts, and cardiac and spine de-
fects. Although no open reading frames crossed the
translocation breakpoint in their proband, the authors
speculated that a position effect was altering the ex-
pression of distant genes. Three forkhead gene–family
members were found in the region near the breakpoint.
FOXC2 was the most likely candidate gene, since it is
known to play a role in the development of several dif-
ferent tissues in mice. Sequencing revealed FOXC2 mu-
tations in two other LD families—a nonsense mutation
that truncated FOXC2, within the conserved forkhead
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domain, and a 4-nucleotide frameshift mutation, located
after the forkhead domain, that also truncated the pro-
tein. Taken together, the mutations suggest that hap-
loinsufficiency of FOXC2 leads to LD. These results pro-
vide further information concerning the role that
FOXC2 plays in human development.
Jejunal Cl5 Section in Cystic Fibrosis, by Ho¨genauer
et al. (p. 1422)
The high carrier frequency for cystic fibrosis (CF) mu-
tations has led many to speculate that there is a hetero-
zygote advantage for these mutations. A likely selective
force for the CF transmembrane-conductance regulator
(CFTR) is secretory diarrhea, since this secretion is me-
diated by the CFTR Cl channel. A reduction in Cl
secretion by the CFTR channel is predicted to reduce
the likelihood of dehydration through diarrhea. In fact,
some studies have indicated that mice heterozygous for
a CFTR mutation do show a reduced intestinal secretion
rate in response to cholera toxin, a classic inducer of
secretory diarrhea (see Ho¨genauer et al.’s citations of
work by Gabriel et al.). Other labs have not seen the
reduced secretion in heterozygous mice, so this hypoth-
esis is controversial. In an attempt to quell this contro-
versy, Ho¨genauer et al. have measured intestinal secre-
tion in patients with CF and in their carrier parents. As
would be expected, the individuals with CF had no active
Cl secretion in their jejunums, even in response to a
prostaglandin analog. In contrast, their heterozygous
parents had levels of Cl secretion that were similar to
that measured in normal individuals. These data do not
support the hypothesis that carriers of CF are protected
from dehydration due to secretory diarrhea. They do,
however, show that CFTR expression is not rate limiting
for active Cl secretion in CF heterozygotes.
Genetics of Thrombosis: The GAIT Study, by Souto et
al. (p. 1452)
Most of the genetic information that we know about
thrombosis has been gleaned through association stud-
ies. To get at this problem from a different angle, Souto
et al. have performed a large family study on thrombosis,
to determine the genetic heritability of this disorder as
well as to examine the correlations between quantitative
risk factors and thrombosis. Surprisingly, they report
that 160% of the variation in susceptibility to throm-
bosis is due to genetic factors. In addition, they find
strong genetic correlations between thrombosis and the
levels of factor VIII, factor IX, factor XI, vonWillebrand
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factor, activated protein C ratio, homocysteine, and tis-
sue-plasminogen activator, indicating that thrombosis
may have genetic influences in common with these phys-
iological parameters. If their models are correct, this
work opens the door to the discovery of quantitative-
trait loci that contribute to the risk of thrombosis.
LD Physical Distance and Population History, by
Dunning et al. (p. 1544)
Just how many SNPs will it take to allow us to perform
a complete genome scan for disease association? Dun-
ning et al. have attacked this question, the current
scourge of genome research, by comparison of linkage
disequilibrium (LD) between genetic regions and be-
tween ethnic populations. In the study, they used mark-
ers with minor-allele frequencies 1.1, in order to make
them comparable with common disease-susceptibility
polymorphisms. The four populations that they have
studied have strikingly different population histories and
include East Anglian British, Afrikaners, Ashkenazim,
and Kuopio Finnish. In contrast to what has been pre-
dicted by other groups, little LD difference was seen
between the populations, making it unlikely that the use
of any one of these populations will be unusually ad-
vantageous in disease association studies. They also find
that LD declines rapidly with distance but is detectable
for markers up to 500 kb apart. An assessment of the
number of marker pairs that show LD amounts that, on
the basis of required sample sizes, would be useful in
association studies revealed that 50% of marker pairs 5
kb apart did not have sufficient LD for these studies. At
20–50-kb spacing, almost none of the markers would
be useful. Since their calculations are based on three
chromosomal regions, their data may not reflect the LD
across the genome, but this work moves us toward a
greater understanding of the LD/distance relationship.
HED, Immunodeficiency, and IKK-gamma Mutations,
by Zonana et al. (p. 1555)
Zonana et al. define a new X-linked syndrome charac-
terized by immunodeficiency and hypohidrotic ecto-
dermal dysplasia (HED-ID). Affected males exhibit dys-
gammaglobulinemia, abnormal dentition, difficulty in
sweating, and sparse scalp hair. Affected males in four
families were found to have mutations in the most 3′
exon of IKK-gamma, a gene that encodes a protein in-
volved in NF-kB activation. This makes HED-ID allelic
to another ectodermal dysplasia, incontinentia pigmenti
(IP). In contrast to HED-ID, IP is almost always lethal
to males. Females with IP have a variety of defects of
the brain, skin, hair, teeth, and eyes. The dominant na-
ture of IP appears to result from a complete loss of IKK-
gamma activity, whereas a partial loss of activity leads
to the less severe, HED-ID phenotype. It remains to be
seen how the other proteins that are associated with
HED phenotypes tie in to the IKK-gamma/ NF-kB sig-
naling pathway.
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